Bolstered by increasing biotech investments and accelerating healthcare research, the biomedical sciences (BMS) industry has experienced strong growth in recent years, further reinforcing Singapore’s position as a leading biomedical science hub at the heart of Asia.
This report provides an overview of Singapore’s BMS industry and its real estate requirements with the focus on key drivers for the industry, demand, future supply and rentals of life science properties.
Biomedical Sciences: A Niche Asset Class with Strong Growth Prospects
07/03/2022
Authors
Related Insights
Research
Life Sciences: COVID-19 Report
Featured local market snapshots give an overview into the life sciences sector and the impact of the pandemic, establishing a baseline for analyzing potential impact in the months to come.
Jolanta Campion • 26/06/2020
Article
The Healthcare Sector – A prescription for future business growth in China
Chinese population demographics in particular are moving in a favourable direction for healthcare companies.
Shaun Brodie • 24/06/2020